Health Care & Life Sciences » Pharmaceuticals | Apex Healthcare Bhd

Apex Healthcare Bhd | Balance Sheet

Fiscal year is January-December. All values MYR Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
36,756.90
56,229.70
69,405.30
82,135.80
86,440.40
Total Accounts Receivable
101,805.70
112,424.00
127,667.50
137,791.10
138,933.30
Inventories
47,742.30
51,697.60
60,865.50
65,777.60
69,017.80
Other Current Assets
120.10
4,648.20
3,015.60
1,826.70
4,832.40
Total Current Assets
186,425.00
224,999.50
260,954.00
287,531.30
299,223.90
Net Property, Plant & Equipment
106,921.00
99,554.50
100,151.00
100,841.30
124,973.80
Total Investments and Advances
13,059.10
18,490.90
27,248.00
18,009.40
20,522.70
Long-Term Note Receivable
5,000.00
10,000.00
-
10,000.00
10,000.00
Intangible Assets
1,190.40
1,222.20
1,736.60
2,021.80
1,970.40
Total Assets
312,971.60
354,435.10
390,213.70
418,407.90
456,903.10
ST Debt & Current Portion LT Debt
-
11.10
12.60
13.00
6.80
Accounts Payable
53,375.20
63,017.80
74,433.30
80,076.30
76,329.50
Income Tax Payable
1,770.80
2,236.30
1,688.20
1,926.90
3,505.00
Other Current Liabilities
16,999.60
23,487.50
20,648.50
19,801.90
30,343.30
Total Current Liabilities
72,145.70
88,752.70
96,782.60
101,818.10
110,184.60
Long-Term Debt
-
32.50
24.20
11.90
-
Deferred Taxes
5,376.40
5,191.00
4,597.90
4,186.50
2,851.00
Total Liabilities
77,898.10
94,144.20
101,528.70
106,020.60
113,247.90
Common Equity (Total)
234,830.70
259,935.20
288,302.40
311,971.10
343,233.90
Total Shareholders' Equity
234,830.70
259,935.20
288,302.40
311,971.10
343,233.90
Total Equity
235,073.50
260,290.90
288,685.00
312,387.30
343,655.20
Liabilities & Shareholders' Equity
312,971.60
354,435.10
390,213.70
418,407.90
456,903.10
Accumulated Minority Interest
242.70
355.60
382.60
416.20
421.30

About Apex Healthcare Bhd

View Profile
Address
1-5 Jalan TTC 1
Melaka Melaka (Malacca) 75250
Malaysia
Employees -
Website http://www.apexpharmacy.com
Updated 09/14/2018
Apex Healthcare Bhd. is an investment holding company, which engages in the manufacture and trade of pharmaceutical and consumer healthcare products. It operates through the following segments: Manufacturing and Marketing; Wholesale and Distribution; and Corporate.